Mutations in SH2B3 have been implicated in acute lymphoblastic leukemia (ALL)48 and have also been identified in myelodysplastic syndrome (MDS) patients who have not progressed to AML49. This evidence concerns the gene SH2B3 and myelodysplastic syndrome.